Marker Therapeutics (MRKR) Operating Margin (2012 - 2026)
Marker Therapeutics (MRKR) operating margin from Dec 31, 2012 to Mar 31, 2026. The current Marker Therapeutics (MRKR) operating margin is -542.67%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Marker Therapeutics (MRKR)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -363.10% | +115.18% |
| 2024 | -168.74% | -61.69% |
| 2023 | -440.48% | -21.87% |
| 2022 | -563.82% | -82.29% |
| 2021 | -3183.87% | -48.20% |
| 2020 | -6146.81% | -42.71% |
| 2019 | -10728.57% | -84.79% |
| 2018 | -70557.14% | +1006.30% |
| 2017 | -6377.78% | N/A |
| 2012 | 0.00% | -100.00% |
| 2011 | 100.00% | N/A |
Comparison Marker Therapeutics (MRKR) operating margin with competitors
Marker Therapeutics (MRKR) operating margin is -542.67%.